肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

Meis2作为MN1诱导的白血病中的关键因子

Meis2 as a critical player in MN1-induced leukemia

原文发布日期:2017-09-29

DOI: 10.1038/bcj.2017.86

类型: Original Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

Meis2作为MN1诱导的白血病中的关键因子

Meis2 as a critical player in MN1-induced leukemia

原文发布日期:2017-09-29

DOI: 10.1038/bcj.2017.86

类型: Original Article

开放获取: 是

 

英文摘要:

Meningioma 1 (MN1) is an independent prognostic marker for normal karyotype acute myeloid leukemia (AML), with high expression linked to all-trans retinoic acid resistance and poor survival. MN1 is also a potent and sufficient oncogene in murine leukemia models, strongly dependent on the MEIS1/AbdB-like HOX protein complex to transform common myeloid progenitors, block myeloid differentiation, and promote leukemic stem cell self-renewal. To identify key genes and pathways underlying leukemic activity, we functionally assessed MN1 cell phenotypic heterogeneity, revealing leukemic and non-leukemic subsets. Using gene expression profiling of these subsets combined with previously published comparisons of full-length MN1 and mutants with varying leukemogenic activity, we identified candidate genes critical to leukemia. Functional analysis identified Hlf and Hoxa9 as critical to MN1 in vitro proliferation, self-renewal and impaired myeloid differentiation. Although critical to transformation, Meis1 knockdown had little impact on these properties in vitro. However, we identified Meis2 as critical to MN1-induced leukemia, with essential roles in proliferation, self-renewal, impairment of differentiation and disease progression in vitro and in vivo. Here, we provide evidence of phenotypic and functional hierarchy in MN1-induced leukemic cells, characterise contributions of Hlf, Hoxa9 and Meis1 to in vitro leukemic properties, and reveal Meis2 as a novel player in MN1-induced leukemogenesis.

 

摘要翻译: 

脑膜瘤蛋白1(MN1)是正常核型急性髓系白血病(AML)的独立预后标志物,其高表达与全反式维甲酸耐药及不良预后相关。在鼠白血病模型中,MN1同样是一种强效且功能完备的致癌基因,其转化共同髓系祖细胞、阻断髓系分化并促进白血病干细胞自我更新的能力高度依赖MEIS1/AbdB样HOX蛋白复合物。为解析白血病活性的关键基因与通路,我们通过功能评估发现MN1细胞存在表型异质性,包括白血病亚群和非白血病亚群。通过对这些亚群进行基因表达谱分析,并结合已发表的全长MN1与不同致瘤活性突变体的比较研究,我们确定了白血病发生的关键候选基因。功能分析显示Hlf和Hoxa9对MN1的体外增殖、自我更新及髓系分化受损过程至关重要。尽管Meis1在细胞转化中不可或缺,其敲除在体外对这些特性影响甚微。然而,我们发现Meis2在MN1诱导的白血病中发挥关键作用,在体外和体内实验中均对细胞增殖、自我更新、分化阻滞及疾病进展具有重要调控功能。本研究揭示了MN1诱导白血病细胞中存在的表型与功能层级结构,明确了Hlf、Hoxa9和Meis1在体外白血病特性中的作用,并首次证实Meis2是MN1诱导白血病发生的新关键因子。

 

原文链接:

Meis2 as a critical player in MN1-induced leukemia

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……